Seung-Seo Lee

Title: Innovations of Seung-Seo Lee in Drug Delivery Systems.

Introduction

Seung-Seo Lee is a notable inventor based in Taejeon, South Korea. He has made significant contributions to the field of drug delivery systems, particularly focusing on colon-selective compositions. His innovative approach aims to enhance the effectiveness of drug delivery to the colon, which is crucial for treating various gastrointestinal conditions.

Latest Patents

One of Seung-Seo Lee's key patents is a colon-selective drug delivery composition. This composition comprises gelatin and a polysaccharide that is degradable by colonic enzymes. Additionally, it may include an aldehyde, a polyvalent metal ion, or another polysaccharide that remains intact in the upper gastrointestinal tract. This innovative formulation allows for the selective delivery of active substances to the colon, ensuring effective release where it is most needed.

Career Highlights

Seung-Seo Lee is associated with Samyang Corporation, where he continues to develop and refine his innovative drug delivery technologies. His work has garnered attention for its potential to improve therapeutic outcomes for patients requiring targeted treatments.

Collaborations

Seung-Seo Lee collaborates with esteemed colleagues, including Chang-Baeg Lim and Sung-Bum La. Their combined expertise contributes to advancing research and development in the field of drug delivery systems.

Conclusion

Seung-Seo Lee's contributions to colon-selective drug delivery compositions represent a significant advancement in pharmaceutical technology. His innovative work continues to pave the way for more effective treatments in gastrointestinal health.